NKG2A/CD159a[Biotin], His & Avi, Human
NKG2A/CD159a[Biotin], His & Avi, Human

Immobilized NKG2A/CD159a[Biotin], His & Avi, Human, His Tag at 1 μg/ml (100 μl/well) on the streptavidin precoated plate(5 μg/ml). Dose response curve for Anti-NKG2A Antibody, hFc Tag with the EC50 of 5.3 ng/ml determined by ELISA.

NKG2A/CD159a[Biotin], His & Avi, Human

Immobilized NKG2A/CD159a[Biotin], His & Avi, Human, His Tag at 2 μg/ml (100 μl/well) on the plate. Dose response curve for Anti-NKG2A Antibody, hFc Tag with the EC50 of 5.7ng/ml determined by ELISA.

NKG2A/CD159a[Biotin], His & Avi, Human

NKG2A/CD159a[Biotin], His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

NKG2A/CD159a[Biotin], His & Avi, Human

NKG2, also known as NKG2A(CD159A), is a member of the killer cell lectin-like receptor family. NKG2A marks a unique immune effector subset preferentially co-expressing the tissue-resident CD103 molecule, but not immune checkpoint inhibitors.It is expressed only in NK-cells, but not in T-cells or B-cells.
Z04567
¥123,118.00

Ask us a question
Product Introduction
Species Human
Protein Construction
Avi His NKG2A/CD159a (Arg100-Leu233)
Accession # P26715-1
N-term C-term
Conjugate Biotin
Purity > 95% as determined by Bis-Tris PAGE
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch.
Expression System HEK293
Theoretical Molecular Weight 18.3 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 40-50 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • NKG2A/CD159a[Biotin], His & Avi, Human
    • NKG2A/CD159a[Biotin], His & Avi, Human

    Immobilized NKG2A/CD159a[Biotin], His & Avi, Human, His Tag at 1 μg/ml (100 μl/well) on the streptavidin precoated plate(5 μg/ml). Dose response curve for Anti-NKG2A Antibody, hFc Tag with the EC50 of 5.3 ng/ml determined by ELISA.

  • NKG2A/CD159a[Biotin], His & Avi, Human
    • NKG2A/CD159a[Biotin], His & Avi, Human

    Immobilized NKG2A/CD159a[Biotin], His & Avi, Human, His Tag at 2 μg/ml (100 μl/well) on the plate. Dose response curve for Anti-NKG2A Antibody, hFc Tag with the EC50 of 5.7ng/ml determined by ELISA.

  • NKG2A/CD159a[Biotin], His & Avi, Human
    • NKG2A/CD159a[Biotin], His & Avi, Human

    NKG2A/CD159a[Biotin], His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background NKG2, also known as NKG2A(CD159A), is a member of the killer cell lectin-like receptor family. NKG2A marks a unique immune effector subset preferentially co-expressing the tissue-resident CD103 molecule, but not immune checkpoint inhibitors.It is expressed only in NK-cells, but not in T-cells or B-cells.
Synonyms NKG2A; NKG2-A; CD94; KLRD1; KP43; KLRC1; CD159A

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.